INTRODUCTION 45
The limited permeability of the outer membrane is a major obstacle for development of novel 46 antimicrobials against Gram-negative pathogens preventing many compounds from reaching their 47 the periplasm, where it can degrade the peptidoglycan. This engineering approach has the potential 93 to utilize multiple distinct phage-derived RBPs to customize the bactericidal spectrum of Innolysins 94 against diverse Gram-negative bacteria. 95 terminus linked by a six amino-acid linker to the Pb5 1-488 in the C-terminus. This result indicates 144 that the binding domain of Pb5 alone can target the bacterial cells and allow phage T5 endolysin to 145 overcome the outer membrane and inhibit E. coli growth. 146
Killing efficiency of Innolysin#6 requires FhuA, but not energy 147
were incubated with the purified Innolysin at a final concentration of 0.2 mg/ml and the reduction in 151 cell counts was compared to the non-treated cells (Fig. 4) . E. coli BL21 cell counts were reduced by 152
1.22 ± 0.12 log after Innolysin treatment and a similar decrease was noticed in E. coli ATCC11303 153 cells (1.09 ± 0.15 log reduction), without prior optimization. No significant effect of the Innolysin 154 was shown in E. coli BL21ΔfhuA, supporting our hypothesis that the Innolysin leads to 155 peptidoglycan degradation when cells harbor the Pb5 receptor FhuA. While FhuA uptake of 156 ferrichrome requires energy from the cytoplasmic proton motive force transduced to the outer 157 membrane via the TonB protein, phage T5 interacts with FhuA independent of TonB (8, 22) . To 158 determine whether activity of Innolysin#6 requires such energy, bactericidal activity was tested 159 against an E. coli tonB deletion mutant (ECOR4ΔtonB) and the wild type ECOR4 as a positive 160 control (Fig 4) . As expected, TonB was not required for bactericidal activity of the Innolysin (Fig.  161   4) . Our combined data demonstrate that Innolysin#6 requires the presence of FhuA in order to be 162 transported passively through the outer membrane and target the peptidoglycan, leading to killing of 163 BL21ΔfhuA was visualized after incubation with Innolysin#6 for 15 min and compared to untreated 168 cells (Fig. 5) . Almost all untreated cells were intact with normal cell envelope morphology. In 169 contrast, treatment of E. coli BL21 with Innolysin#6 led to cell integrity damage in the majority of 170 cells with cytosol leakage occurring mainly at the poles. Furthermore, periplasmic space appeared 171 to widen with the outer membrane disconnecting from the inner membrane and cell debris could be 172 detected likely due to cell lysis. This dramatic effect on cell morphology was not observed on E. 173 coli BL21ΔfhuA treated with Innolysin#6, where only a low increase in damaged cells was noticed 174 compared to the untreated cells. These observations demonstrate that Innolysin#6 acts rapidly by 175 interfering with membrane integrity, while presence of FhuA is required for Innolysin to exert high 176 antimicrobial activity. 177
Innolysin targets FhuA homologs of other than E. coli species 178
To investigate whether the constructed Innolysin#6 could target FhuA homologs in other species, 179
we tested the killing activity of the purified engineered protein against Shigella sonnei, Salmonella 180 Typhimurium LT2c and Pseudomonas aeruginosa PAO1 (Fig. 6 ). These bacteria carry FhuA 181 homologs with identity ranging between 22.6 and 99.6% to the FhuA of E. coli BL21 (see Table S2 182 in the supplemental material). The Innolysin killed S. sonnei (99.6% FhuA identity at the protein 183 level) and P. aeruginosa PAO1 (less than 39% FhuA identity), leading to average log reductions in 184 cell number of 1.52 ± 0.14 and 1.03 ± 0.25, respectively. In contrast, no significant reduction of 185 Salmonella Typhimurium LT2c was noticed, despite the high similarity between the FhuA homolog 186 in this strain and FhuA of E. coli BL21 (76.53% FhuA identity). Alignment of FhuA homologs 187
showed that in comparison to FhuA of S. sonnei and E. coli, FhuA of Salmonella Typhimurium 188 LT2c lacks 17 amino acids which are part of the surface-exposed L4 loop of E. coli FhuA (Fig. 7) 189 (8). P. aeruginosa PAO1 lacks FhuA, however, it harbors other outer membrane proteins involved 190 in the bacterial iron-uptake, including FpvA, FpvB, FptA, FiuA and FoxA (23) . Alignment of E.
coli FhuA with these proteins revealed a low percent identity ranging between 22.61 and 38.52% 192 (see Table S2 ). Notably, the amino-acid sequence responsible for L4 loop formation of FhuA 193 aligned to parts of the outer membrane proteins FptA and FpvA of P. aeruginosa (Fig. S1 ) which, 194 based on their tertiary structure predictions, form surface-exposed loops (24, 25) . This observation 195 suggests that such loops may interact with the Innolysin. In summary, we conclude that the 196
DISCUSSION 198
Phages have developed unique and complex mechanisms to infect and lyse bacteria. In the first 199 Here we showed that the bactericidal activity of Innolysin#6 consisting of T5 endolysin, a small 211 linker and the binding domain of Pb5, is dependent on FhuA receptor of phage T5 (5, 6). Similar to 212 phage T5 binding and DNA injection (22, 26, 27) , the antimicrobial activity of Innolysin#6 is 213 independent of energy provided by TonB, indicating that Innolysin#6 is passively transported to the 214 peptidoglycan. Microscopic analysis revealed that Innolysin#6 causes cytosol leakage mainly from 215 the bacterial poles of wild type E. coli encoding FhuA. Interestingly, several phages have been 216
shown to preferentially adsorb at the bacterial poles, including E. coli phage φ80 that uses FhuA as 217 receptor (28). Thus, Innolysin#6 may bind to FhuA of E. coli in a similar manner as phage T5 218 causing specific lysis of cells carrying the FhuA receptor of Pb5.ferrichrome, it is tempting to speculate that Innolysin is transported passively through the channel. /Ca 2+ ions due to the 243 high isoelectric point of phage T5 endolysin (7.91), thus destabilizing the ionic forces in the outermembrane (33). A similar mode of action has been described for Artilysins, endolysins engineered 245 with polycationic or amphipathic peptides that destabilize the outer membrane and target the 246 endolysins to peptidoglycan (14). Furthermore, we found that a linker between the T5 endolysin 247
and Pb5 1-488 components is essential for bactericidal activity. Similarly, modular endolysins contain 248 flexible interdomain linkers, which are important for enzyme activity (34). Thus, the linker may be 249 necessary for the Innolysin to properly bind to the receptor FhuA, interfere with the membrane 250 integrity and overcome the outer membrane. 251
FhuA is conserved in bacterial species including Escherichia, Shigella and Salmonella and is 252 structurally homologous to other Ton-B dependent outer membrane receptors involved in bacterial 253 iron uptake (35). The Innolysin showed antimicrobial activity towards Shigella sonnei andcan target non-actively growing bacteria, since they bypass the outer membrane passively (38). 268
Additionally, Innolysins can be designed to target important virulent determinants such as OmpX in 269
Escherichia coli and Ail in Yersinia pestis, in order to modulate virulence (39, 40). Although 270 further experiments are needed for optimizing the activity of such antimicrobials and for elucidating 271 the exact mechanism by which Innolysins bypass the outer membrane, our findings provide a 272 promising approach to design novel therapeutic agents with a highly customizable bactericidal 273 spectrum. 274
MATERIAL AND METHODS 275

Bacterial strains 276
E. coli BL21-CodonPlus-(DE3)-RIL (Agilent Technologies) was used for expression ofon the chromosomes of E. coli BL21 (DE3) and E. coli ECOR4, respectively, were previously 282 generated by the Lambda red recombination system as described before (44). Briefly, the 283 kanamycin cassette from plasmid pKD4 was amplified (Pfu polymerase; Thermo Fisher Scientific, 284
Waltham, MA) with oligonucleotides carrying ~39 nucleotide extensions homologous to regions 285 adjacent to the target gene (custom primers, Table S1 ). The amplicon was purified with QIAquick 286 PCR Purification Kit (Qiagen) and electroporated into competent cells. Kanamycin-resistant clones 287
were selected and insertion of the kanamycin cassette was verified by PCR.
Cloning of constructs 289
Genomic material was purified from phage T5 (Leibniz Institute) and used as a template for 290 amplification (Pfu polymerase; Thermo Fisher Scientific, Waltham, MA) of the genes encoding T5 291 endolysin (YP_006868.1) or Pb5 (YP_006985.1) with specific primers (Table S1 ). The linkers were 292 created as primer cassettes. The specific primers were mixed, heated to 95°C and gradually cooled 293 down for hybridization. Each assembly encoding the different fragments of the fusion proteins was 294 constructed by Type IIs cloning. Amplicons or primer cassettes (each 50 ng/µl) were mixed with 295 100 ng/µl pNICBsa4, in which the N-terminal His-tag was exchanged for a C-terminal His-tag, and 296
BsaI and T4 DNA ligase were added. The mixture was incubated alternatingly at 37°C and 16°C 297 (50 cycli) and heat inactivated at 80°C. Transformation of E. coli BL21-CodonPlus-(DE3)-RIL was 298 conducted and transformants were selected in the presence of kanamycin (100 μg/ml) and 299 chloramphenicol (50 μg/ml). 300
Protein expression and purification 301
Recombinant proteins were simultaneously expressed in a 96 deep-well plate. Freshly transformed 302 colonies were resuspended in 500 μl of auto-induction medium (93% ZY medium, 0.05% 2M 303 MgSO 4 , 2% 50x 5052, 5% 20x NPS) and incubated at 37 °C for 5 hours, followed by 16 °C for 40 304 hours, both at 900 rpm. Cells were spun down by centrifugation (3,200 × g, 30 min, 4°C) and the 305 supernatants were removed. Cell pellets were lysed by exposure to chloroform vapor, by placing the 306 deep-well plate upside-down in a glass petri dish containing chloroform-saturated filters for 2 h. 307
Cell lysates were resuspended in 20 mM HEPES-NaOH (pH 7.4), and 1 U DNase I, followed by 308 incubation (100 × rpm, 1 hour, 30 °C). Insoluble fractions of cell lysates were removed by 309 centrifugation (3,200 × g for 30 min, at 4°C) and the supernatants containing the soluble fractions 310 of the lysates were screened for both muralytic and inhibitory activities.
For large-scale expression of the Innolysin#6, a 1 L expression culture (LB medium) was induced 312 with 1 mM isopropyl-beta-D-thiogalactopyranoside (Thermo Fisher Scientific) in the mid-313 logarithmic phase (OD 600 =0.6). Incubation of the culture was followed at 16°C for eighteen hours at 314 120 rpm. Cells were harvested by centrifugation (8,000 × g, 10 min, 4°C) and the cell pellet was 315 resuspended in 10 ml of lysis buffer (20 mM NaH 2 PO 4 -NaOH, 0.5 M NaCl, 50 mM imidazole, pH 316 7.4), followed by sonication (Bandelin Sonopul HD 2070 homogeniser) with 10 bursts of 30 sec 317 (amplitude of 50%) with 30 sec intervals. Protein lysate was double-filtered using filters with pore 318 size of 0.22 μm. His GraviTrap TM gravity flow columns (GE Healthcare) were used for His-tagged 319 protein purification according to the manufacturer's instructions. Buffer exchange was performed 320 with 20 mM HEPES-NaOH (pH 7.4) by using Amicon R Ultra -4 centrifugal filters with 50 kDa 321 cutoff (Merck Millipore) and protein concentration was measured by Qubit TM Protein Assay Kit 322 (Q33211) in Qubit 2.0 Fluorometer (Invitrogen, Q32866). 323
Muralytic assay 324
Analysis of the muralytic activity was conducted as described before (14, 45) using outer membrane 325 Escherichia coli K-12 using PCR products. Proceedings of the National Academy of 531 orange to grey to represent higher conservation. Conservation with no threshold was used by 600 Jalview sequence alignment tool. The red box highlights the alignment of P. aeruginosa 601 homologous proteins to the amino acid sequence of FhuA responsible for the formation of the 602 surface-exposed part of loop L4 in E.coli BL21. 603 Table S1 : Primers used for PCR amplification in cloning 604
FIGURE LEGENDS
For generating mutations in E. coli strains, primers were designed with regions of homology to the 
